CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
London, United Kingdom and 80 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Enfield Town, United Kingdom and 125 other locations
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
London, United Kingdom and 76 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
High Wycombe, United Kingdom and 45 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Enfield Town, United Kingdom and 117 other locations
12 years old with moderate to severe asthma....
Phase 2
London, United Kingdom and 19 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
London, United Kingdom and 97 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
London, United Kingdom and 132 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
London, United Kingdom and 350 other locations
with amlitelimab in adult participants with moderate-to-severe asthma.Study details include:The study duration (per participant) will be up ...
Phase 2
London, London, City Of, United Kingdom and 122 other locations
Clinical trials
Research sites
Resources
Legal